We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Needle-Free Transdermal System for Pain

By HospiMedica staff writers
Posted on 08 Apr 2004
A study has found that a needle-free, self-contained fentanyl patient-controlled transdermal system (PCTS) is as effective for postsurgical pain management as a traditional intravenous (IV) pump. More...
The finding was reported in the March 17, 2004, issue of the Journal of the American Medical Association (JAMA).

The multicenter study, conducted at more than 30 sites, showed that a button-activated fentanyl system that delivers pain medication through the skin could eliminate the need for IVs for postsurgical pain relief. This system, known as E-TRANS fentanyl PCTS, also offers the advantage of a needle-free pre-programmed medication system in a small, self-contained unit.

"This is a miracle of miniaturization,” said Eugene Viscusi, M.D., director of the acute pain management service at Thomas Jefferson University Hospital (Philadephia, PA, USA), who led the study.

The system, about the size of a credit card, is self-adherent to the skin. It can be used for patients with moderate-to-severe postoperative pain after most surgeries, including joint replacement, prostate surgery, or gynecologic surgeries. The PCTS is placed on an inpatient's upper arm or chest by adhesive on the back of the patch. When a patient pushes the button for pain, PCTS delivers the medication over 10 minutes. A lockout feature prevents a patient from administering more pain medication than the doctor prescribed. Without tubing or other equipment, the patient can move freely about.

The system was developed by Ortho-McNeil Pharmaceuticals, Inc. (Raritan, NJ, USA) and the Alza Corporation (Mountain View, CA, USA).


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.